ChemoCentryx Inc (NASDAQ:CCXI)

10.82
Delayed Data
As of Apr 20
 -0.09 / -0.82%
Today’s Change
5.42
Today|||52-Week Range
15.08
+81.85%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$594.5M

Company Description

ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in Mountain View, CA.

Contact Information

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View California 94043
P:(650) 210-2900
Investor Relations:

Employees

Shareholders

Individual stakeholders44.51%
Other institutional32.78%
Mutual fund holders17.10%

Top Executives

Thomas J. SchallChairman, President & Chief Executive Officer
William FaireyChief Operating Officer & Executive Vice President
Susan M. KanayaCFO, Secretary, CAO & Principal Accounting Officer
Rajinder SinghSenior Vice President-Research
Jan L. HillsonSenior Vice President-Drug Development